Cited by 256Tuberculosis Research and EpidemiologyMedication Adherence and ComplianceHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City

Open access

Pablos-Méndez, MD, MPH, Ariel, Knirsch, MD, MPH, Charles A, Barr, MD, R.Graham, Lerner, MD, PhD, Barron H, Frieden, MD, MPH, Thomas R·1997·The American Journal of Medicine

DOI 10.1016/s0002-9343(96)00402-0

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Poor adherence to antituberculosis treatment is the most important obstacle to tuberculosis control. PURPOSE: To identify and analyze predictors and consequences of nonadherence to antituberculosis treatment. PATIENTS AND METHODS: Retrospective study of a citywide cohort of 184 patients with tuberculosis in New York City, newly diagnosed by culture in April 1991-before the strengthening of its control program-and followed up through 1994. Follow-up information was collected through the New York City tuberculosis registry. Nonadherence was defined as treatment default for at least 2 months. RESULTS: Eighty-eight of the 184 (48%) patients were nonadherent. Greater nonadherence was noted among blacks (unadjusted relative risk [RR] 3.0, 95% confidence interval [CI] 1.1 to 8.6, compared with whites), injection drug users (RR 1.5, 95% CI 1.1 to 2.0), homeless (RR 1.4, 95% CI 1.0 to 1.8), alcoholics (RR 1.4, 95% CI 1.0 to 1.9), and HIV-infected patients (RR 1.4, 95% CI 1.1 to 1.9); also, census-derived estimates of household income were lower among nonadherent patients (P = 0.018). In multivariate analysis, only injection drug use and homelessness predicted nonadherence, yet 46 (39%) of 117 patients who were neither homeless nor drug users were nonadherent. Nonadherent patients took longer to convert to negative culture (254 versus 64 days, P < 0.001), were more likely to acquire drug resistance (RR 5.6, 95% CI 0.7 to 44.2), required longer treatment regimens (560 versus 324 days, P < 0.0001), and were less likely to complete treatment (RR 0.5, 95% CI 0.4 to 0.7). There was no association between treatment adherence and all-cause mortality. CONCLUSIONS: In the absence of public health intervention, half the patients defaulted treatment for 2 months or longer. Although common among the homeless and injection drug users, the problem occurred frequently and unpredictably in other patients. Nonadherence may contribute to the spread of tuberculosis and the emergence of drug resistance, and may increase the cost of treatment. These data lend support to directly observed therapy in tuberculosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0002-9343(96)00402-0

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Global Epidemiology of Tuberculosis
Raviglione, M. C. (1995) · JAMA · doi:10.1001/jama.273.3.220 · Cited by 1,754
Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.
Krieger, N. R. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,661
Compliance in Health Care
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children. American Thoracic Society and the Centers for Disease Control and Prevention
Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F. L., Snider, D. E., & Thornton, G. F. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,190
The Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T. R., Pablos-Méndez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 937
TEST OF THE NATIONAL DEATH INDEX
Stampfer, M. J., Willett, W. C., Speizer, F. E., DYSERT, D. C., LIPNICK, R. J., ROSNER, B. A., & Hennekens, C. H. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113804 · Cited by 791
Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs
Brudney, K. F., & Dobkin, J. F. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.745 · Cited by 651
SPSS for Windows: Advanced Statistics Release 5
Norušis, M. J. (1992) · Medical Entomology and Zoology · Cited by 644
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 644

Show all 54 references

Research works printed but not linked: 1

Approaches to improving adherence to antituberculosis therapy—South Carolina and New York, 1986 1991. MMWR. 1993;42:74–75.

Sorted by citations

No health without mental health
Prince, M. J., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 4,028
Homelessness and Health
Hwang, S. W. (2002) · Journal of Heredity · doi:10.1093/jurban/79.suppl_1.s141 · Cited by 719
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
Haubrich, R., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., Johnson, D., Dubé, M. P., Hwanga, J. Y., & McCutchan, J. A. (1999) · AIDS · doi:10.1097/00002030-199906180-00014 · Cited by 531
Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.
(2002) · PubMed Central · Cited by 522
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.
Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M., & Fortune, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2656 · Cited by 457
Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes
Grant, R. W., Devita, N. G., Singer, D. E., & Meigs, J. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1408 · Cited by 403
“Results from studies that have assessed concurrent adherence in multidrug therapy for HIV disease (11–13) and for tuberculosis treatment (14,15) may not be generalizable to the treatment of patients with type 2 diabetes, who tend to be older, are often asymptomatic, and take medicines largely for preventive purposes.”
Background
Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling
Gumbo, T., Louie, A., Deziel, M. R., Parsons, L. M., Salfinger, M., & Drusano, G. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/424849 · Cited by 315
“ability of emergence of drug resistance [6–9].”
Homelessness and Health in Canada: Research Lessons and Priorities
Frankish, C. J., Hwang, S. W., & Quantz, D. (2005) · Canadian Journal of Public Health · doi:10.1007/bf03403700 · Cited by 286
Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: A case control study
Muture, B. N., Keraka, M. N., Kimuu, P. K., Kabiru, E. W., Ombeka, V. O., & Oguya, F. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-696 · Cited by 243
Tuberculosis in London: the importance of homelessness, problem drug use and prison
Story, A., Murad, S., Roberts, W., Verheyen, M., Hayward, A. C., & for the London Tuberculosis Nurses Network (2007) · Thorax · doi:10.1136/thx.2006.065409 · Cited by 227
Tuberculosis and Illicit Drug Use: Review and Update
Deiss, R., Rodwell, T. C., & Garfein, R. S. (2008) · Clinical Infectious Diseases · doi:10.1086/594126 · Cited by 224
“Studies have reported that IDUs have difficulty completing medical evaluations [27, 35, 95] and/or adhering to treatment for LTBI [35] or TB disease [96].”
Background
Geography, ecology and emerging infectious diseases
Mayer, J. D. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00346-9 · Cited by 216
“One recent study, for example, found that nearly 50% of those people enrolled in a tuberculosis treatment program in New York City adhered to the program and many people dropped out and even disappeared into the vortex of impoverishment and homelessness (Pablos-Mendez et al., 1997). In these same neighborhoods, condit…”
BackgroundInfluential
The rise and fall of antimicrobial resistance
Lipsitch, M. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02130-8 · Cited by 190
Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients
Pachi, A., Bratis, D., Moussas, G., & Tselebis, A. (2013) · Tuberculosis Research and Treatment · doi:10.1155/2013/489865 · Cited by 185
Long-Term Survival and Valve-Related Complications in Young Women With Cardiac Valve Replacements
North, R. A., Sadler, L. C., Stewart, A. W., McCowan, L. M. E., KERR, A. R., & White, H. D. (1999) · Circulation · doi:10.1161/01.cir.99.20.2669 · Cited by 173
Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance
Gelmanova, I. Y. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038331 · Cited by 167
Factors Influencing Physicians’ Judgments of Adherence and Treatment Decisions for Patients with HIV Disease
Bogart, L. M., Catz, S. L., Kelly, J. A., & Benotsch, E. G. (2001) · Medical Decision Making · doi:10.1177/0272989x0102100104 · Cited by 163
Risk Factors and Mortality Associated with Default from Multidrug‐Resistant Tuberculosis Treatment
Franke, M. F., Appleton, S. C., Bayona, J. N., Arteaga, F., Palacios, E., Llaro, K., Shin, S. S., Becerra, M. C., Murray, M. B., & Mitnick, C. D. (2008) · Clinical Infectious Diseases · doi:10.1086/588292 · Cited by 144
“These include patientrelated factors, such as alcoholism, drug use, treatment-related adverse events, prior treatment default, lack of social support, and low socioeconomic status [10–15], and programmatic risk factors, such as poor patient-provider communication and barriers to accessing care [16–18].”
Background
Prevention and treatment of hepatitis C in injection drug users
Edlin, B. R. (2002) · Hepatology · doi:10.1053/jhep.2002.36809 · Cited by 163
Rethinking Nonadherence: Historical Perspectives on Triple-Drug Therapy for HIV Disease
Lerner, B. H., Gulick, R. M., & Dubler, N. N. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-7-199810010-00012 · Cited by 141
“For example, in one recent study that found an association between injection drug use and nonadherence to tuberculosis therapy (48), 40% of all drug users completed treatment—without directly observed therapy.”
Background
Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
Svensson, E. M., Murray, S. R., Karlsson, M. O., & Dooley, K. E. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku504 · Cited by 130
Enhancing management of tuberculosis treatment with video directly observed therapy in New York City
Chuck, C., Robinson, E. W., Macaraig, M., Alexander, M., & Burzynski, J. N. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0738 · Cited by 124
Non‐adherence in pediatric liver transplant recipients − an assessment of risk factors and natural history
Lurie, S., Shemesh, E., Sheiner, P. A., Emre, S., Tindle, H. L., Melchionna, L., & Shneider, B. L. (2000) · Pediatric Transplantation · doi:10.1034/j.1399-3046.2000.00110.x · Cited by 123
An Observed Performance Test of Medication Management Ability in HIV: Relation to Neuropsychological Status and Medication Adherence Outcomes
Albert, S. M., Weber, C., Todak, G. G., Polanco, C., Clouse, R., McElhiney, M. C., Rabkin, J. G., Stern, Y., & Marder, K. S. (1999) · AIDS and Behavior · doi:10.1023/a:1025483806464 · Cited by 121
“It is likely that some of the low adherence reported for people with HIV (Alwood et al., 1994; Galetko et al., 1996; Muma et al., 1995; Pablos-Mendez et al., 1997; Samet et al., 1992; Stall et al., 1996; Wall et al., 1995) may be due to such deficits.”
Background
Molecular Fingerprinting of Mycobacterium tuberculosis and Risk Factors for Tuberculosis Transmission in Paris, France, and Surrounding Area
Gutierrez, M. C., Vincent, V., Aubert, D., Bizet, J., Gaillot, O., Lebrun, L., Lependeven, C., Pennec, M. P. L., Mathieu, D., Offredo, C., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.486-492.1998 · Cited by 117
“These patients also poorly adhere to treatment, which is linked to longer periods for conversion to a negative culture, longer treatment regimens, and treatment failure (12, 23).”
Background
Tuberculosis and Substance Abuse in the United States, 1997-2006
Oeltmann, J. E., Kammerer, J. S., Pevzner, E. S., & Moonan, P. K. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.535 · Cited by 109
Non-Adherence of New Pulmonary Tuberculosis Patients to Anti-Tuberculosis Treatment
Kulkarni, P. V., Akarte, S., Mankeshwar, R., Bhawalkar, J., Ak, B., & Kulkarni, A. (2013) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.109507 · Cited by 101
“Lack of family and social support predicts poor treatment adherence.[9,21,33] In our study, patients not living with own family were observed to be more non‐adherent to the treatment as compared to patients living with family.”
Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
Finlay, A. M., Lancaster, J., Holtz, T. H., Weyer, K., Miranda, A., & der Walt, M. L. V. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-56 · Cited by 96
“Persons under treatment for TB who default from treatment are at risk for clinical deterioration and complications, can continue to be infectious to others, and are at risk of premature death from TB [3].”
Background
The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes – A Systematic Review and Meta-Analysis
van Hoorn, R., Jaramillo, E., Collins, D., Gebhard, A. C., & van den Hof, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154095 · Cited by 94
Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review
Gennaro, F. D., Pizzol, D., Cebola, B. R., Stubbs, B., Monno, L., Saracino, A., Luchini, C., Solmi, M., Segafredo, G., Putoto, G., et al. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.01.002 · Cited by 94
A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
Ford, M. E., Havstad, S. L., & Davis, S. D. (2004) · Clinical Trials · doi:10.1191/1740774504cn029oa · Cited by 91
“By using geographic information system (GIS) technology, a computer mapping and analysis technology capable of linking geographic with demographic information [29], census data were used to assign each study participant the average household income in the block-group of residence (a subdivision of a census tract repre…”
Method
Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study
Garrido, M. D. S., Penna, M. L. F., Pérez-Porcuna, T. M., Souza, A. B., Marreiro, L. D. S., de Albuquerque, B. C., Martínez-Espinosa, F. E., & Bührer-Sékula, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039134 · Cited by 87
“It may lead to persistence of infectious source, increased mortality, increased relapse rates, and facilitate the development of resistant strains [4,5].”
Background
Association of Major Depressive Episode with Negative Outcomes of Tuberculosis Treatment
Ugarte‐Gil, C., Ruiz, P., Zamudio, C., Canaza, L., Otero, L., Kruger, H., & Seas, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069514 · Cited by 91
“Non-adherence is related with increasing cases of MDR-TB and negative outcomes as death or clinical complications [4].”
Background
A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection.
Nyamathi, A., Christiani, A., Nahid, P., Gregerson, P., & LEAKE, B. D. (2006) · PubMed · Cited by 83
Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa
Kigozi, G., Heunis, C., Chikobvu, P., Botha, S., & van Rensburg, D. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.11.407 · Cited by 76
Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia
Getahun, B., Ameni, G., Biadgilign, S., & Medhin, G. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-127 · Cited by 77
“Previously reported risk factors of mortality among tuberculosis patients include advanced human immunodeficiency virus (HIV) infection [35,36], multidrug resistance [36-38], and irregular treatment [39].”
Background
Adherence is associated with the quality of professional–patient interaction in Directly Observed Treatment Short-course, DOTS
Mishra, P., Hansen, E. H., Sabroe, S., & Kafle, K. K. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2005.08.006 · Cited by 77
A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users
Batki, S. L., Gruber, V. A., Bradley, J. M., Bradley, M., & Delucchi, K. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00208-3 · Cited by 75
“Fifth, in order to identify who was most and least likely to complete INH chemoprophylaxis, the study evaluated several drug use, psychiatric, and psychosocial variables as possible predictors of completion (Burman et al., 1997; Pablos-Maendez et al., 1997; Tulsky et al., 2000).”
Background
HIV-related knowledge and adherence to HAART
Weiss, L., French, T., Finkelstein, R., Waters, M., Mukherjee, R., & Agins, B. (2003) · AIDS Care · doi:10.1080/09540120310001595159 · Cited by 73
“However, adherence to medical recommendations is rarely so high (Darnell et al. , 1986; Pablos-Mendez et al. , 1997; Svensson et al. , 2000), even among those with HIV Address for correspondence: Linda Weiss, , PhD, Senior Research Associate, Office of Special Populations, New York Academy of…”
Background
Health Culture and the Clinical Encounter: Vietnamese Refugees' Responses to Preventive Drug Treatment of Inactive Tuberculosis
Ito, K. L. (1999) · Medical Anthropology Quarterly · doi:10.1525/maq.1999.13.3.338 · Cited by 72
The DOTS Strategy for Controlling the Global Tuberculosis Epidemic
Frieden, T. R., & Munsiff, S. S. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.02.001 · Cited by 70
“[42] Pablos-Mendez A, Knirsch CA, Barr RG, et al.”
Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia
Ruru, Y., Matasik, M., Oktavian, A., Senyorita, R., Mirino, Y., Tarigan, L. H., van der Werf, M. J., Tiemersma, E. W., & Alisjahbana, B. (2018) · Global Health Action · doi:10.1080/16549716.2018.1510592 · Cited by 69
“Incomplete TB treatment may cause prolonged TB transmission, increased risk of development of drugresistant TB, and higher mortality [1].”
Background
Tuberculosis Mortality During a Civil War in Guinea-Bissau
Gustafson, P. (2001) · JAMA · doi:10.1001/jama.286.5.599 · Cited by 69
Crack Cocaine and Infectious Tuberculosis
Story, A., Bothamley, G. H., & Hayward, A. C. (2008) · Emerging infectious diseases · doi:10.3201/eid1409.070654 · Cited by 67
“Drug users are more likely than non–drug users to default treatment, to remain infectious for prolonged periods after diagnosis, and to acquire drug-resistant TB (15).”
Background
Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease
Quinn, C. M., Poplin, V., Kasibante, J., Yuquimpo, K., Gakuru, J., Cresswell, F. V., & Bahr, N. C. (2020) · Life · doi:10.3390/life10110262 · Cited by 64
“Poor adherence is especially common in those with TB and HIV [28], and a thorough exploration of barriers to treatment is important when nonadherence or IRIS is suspected.”
Background
Does directly observed therapy (DOT) reduce drug resistant tuberculosis?
Moonan, P. K., Quitugua, T. N., Pogoda, J. M., Woo, G., Drewyer, G., Sahbazian, B., Dunbar, D. F., Jost, K. C., Jr., Wallace, C. E., & Weis, S. E. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-19 · Cited by 64
“Not only are patients infected with strains resistant to multiple drugs less likely to be cured, but the treatment is more toxic and expensive than treatment of patients with susceptible organisms [5,37-39].”
Background
Which Patients Are Able To Adhere to Tuberculosis Treatment? A Study in a Rural Area in the Northwest Part of Turkey
Balbay, Ö., Annakkaya, A. N., Arbak, P., Bílgín, C., & Erbaş, M. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.152 · Cited by 63
“Patient who refused treatment from the start were also considered nonadherent (20,21).”
Background
Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa
Bionghi, N., Daftary, A., Maharaj, B., Msibi, Z. N. P., Amico, K. R., Friedland, G. H., Orrell, C., Padayatchi, N., & O’Donnell, M. R. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3080-2 · Cited by 60
Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients.
Naing, N. N., D’Este, C. A., Isa, A. R., Salleh, R., Bakar, N., & Mahmod, M. R. (2001) · PubMed · Cited by 60
Antimicrobial activity of the new endophytic Monodictys castaneae SVJM139 pigment and its optimization
Sonaimuthu, V., & Muthumary, J. (2010) · African Journal of Microbiology Research · doi:10.5897/ajmr.9000079 · Cited by 59
Tuberculosis and excess alcohol use in the United States, 1997–2012
Volkmann, T. A., Moonan, P. K., Miramontes, R., & Oeltmann, J. E. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0516 · Cited by 59
Association Between Neighborhood-level Socioeconomic Deprivation and the Medication Level Variability Index for Children Following Liver Transplantation
Wadhwani, S. I., Bucuvalas, J. C., Brokamp, C., Anand, R., Gupta, A., Taylor, S. C., Shemesh, E., & Beck, A. F. (2020) · Transplantation · doi:10.1097/tp.0000000000003157 · Cited by 59
“medication adherence,(10-15) the impact of neighborhood socioeconomic deprivation on medication adherence has been underexplored.(6,16-24) Indeed, we found no studies in children or adults following solid organ transplantation that have evaluated the impact of neighborhood deprivation on a direct surrogate measure(25)…”
Background
Estudo caso-controle de indicadores de abandono em doentes com tuberculose
Ribeiro, S. A., Amado, V. M., Camelier, A. A., FERNANDES, M. M. A., & Schenkman, S. (2000) · Jornal de Pneumologia · doi:10.1590/s0102-35862000000600004 · Cited by 57
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E., Wiggins, T. J., & Berney, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.611683 · Cited by 54
The Client Adherence Profiling-Intervention Tailoring (CAP-IT) Intervention for Enhancing Adherence to HIV/AIDS Medications: A Pilot Study
Holzemer, W. L., Henry, S. B., Portillo, C. J., & Miramontes, H. M. (2000) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/s1055-3290(06)60420-2 · Cited by 56
Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru
Lackey, B., Seas, C., der Stuyft, P. V., & Otero, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128541 · Cited by 55
Adherence to Tuberculosis Treatment, Sputum Smear Conversion and Mortality: A Retrospective Cohort Study in 48 Rwandan Clinics
Kayigamba, F. R., Bakker, M. I., Mugisha, V., Naeyer, L. D., Gasana, M., Cobelens, F. G. J., & van der Loeff, M. F. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073501 · Cited by 54
“Poor adherence to treatment may prolong infectiousness and increases the risk of drug resistance, relapse, and death, as well as onward transmission [3,9].”
Background
The behavior of PLGA microspheres containing rifampicin in alveolar macrophages
Onoshita, T., Shimizu, Y., Yamaya, N., Miyazaki, M., Yokoyama, M., Fujiwara, N., Nakajima, T., Makino, K., Terada, H., & Haga, M. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.10.036 · Cited by 54
High prevalence of multidrug-resistant tuberculosis in Georgia
Mdivani, N., Zangaladze, E., Volkova, N., Kourbatova, E. V., Jibuti, T., Shubladze, N., Kutateladze, T., Khechinashvili, G., del Rı́o, C., Salakaia, A., et al. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.03.012 · Cited by 54
“Also it has been demonstrated that injection drug use is a signiﬁcant predictor of TB treatment nonadherence, 30 which may impact the development of resistance.”
Background
Abandono do tratamento da tuberculose pulmonar em Cuiabá - MT - Brasil
Ferreira, S. M. B., da Silva, A. M. C., & Botelho, C. F. (2005) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132005000500011 · Cited by 53
Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
Ankomah, P., & Levin, B. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002487 · Cited by 53
“Additionally, while our model takes into account three forms of the non-adherence that is considered to be one of the major contributory factors to TB treatment failure [43,45,51], it certainly does not incorporate all of the nuances of non-adherence.”
BackgroundMethod
Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria
Otu, A. A., Umoh, V. A., Habib, A., Ameh, S., Lawson, L., & Ansa, V. O. (2013) · Pulmonary Medicine · doi:10.1155/2013/235190 · Cited by 52
“This could thus result in treatment failure and foster emergence of drug-resistant TB and may increase the cost of treatment [21].”
Background
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
Kumar, P., Capodagli, G. C., Awasthi, D., Shrestha, R., Maharaja, K., Sukheja, P., Li, S.-G., Inoyama, D., Zimmerman, M. D., Liang, H.-P. H., et al. (2018) · mBio · doi:10.1128/mbio.02101-17 · Cited by 51
Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study
Holzman, S. B., Atre, S. R., Sahasrabudhe, T. R., Ambike, S., Jagtap, D., Sayyad, Y., Kakrani, A. L., Gupta, A., Mave, V., & Shah, M. (2019) · JMIR Formative Research · doi:10.2196/13411 · Cited by 50
“To achieve positive treatment outcomes, adherence to TB therapy is critical [2,3].”
Background
Preparing short message service reminders to improve treatment adherence among tuberculosis patients in Sleman District, Indonesia
Dewi, F. S. T., Sudiya, S., Supriyati, S., Purwanta, P., Madyaningrum, E., Aulia, F. U., Wardiani, R., & Utarini, A. (2019) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_207_18 · Cited by 47
“The nonadherence to treatment can increase transmission, drug resistance,[3] the need for more expensive treatment,[4] and mortality.”
Background
Extrapulmonary tuberculosis in the northeastern suburbs of Paris: 141 cases
Fain, O., Lortholary, O., Lascaux, V., Amoura, I., Babinet, P., Beaudreuil, J., Boudon, P., Cruaud, P., Desrues, J., Djouab, M., et al. (2000) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(00)00076-5 · Cited by 47
When should we delay highly active antiretroviral therapy?
Bangsberg, D. R., & Moss, A. R. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.05109.x · Cited by 47
Adherence to Multidrug Resistant Tuberculosis Treatment and Case Management in Chongqing, China – A Mixed Method Research Study
Xing, W., Zhang, R., Jiang, W., Zhang, T., Pender, M., Zhou, J., Pu, J., Liu, S., Wang, G., Chen, Y., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s293583 · Cited by 48
More Than Malnutrition: A Review of the Relationship Between Food Insecurity and Tuberculosis
Balinda, I. G., Sugrue, D. D., & Ivers, L. C. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz102 · Cited by 49
“Studies have shown that individuals with substance use disorders present late for TB treatment [93, 94] and have difficulty adhering to TB treatment [44, 95], thereby increasing”
Background
Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine
Morozova, O., Дворяк, С., & Altice, F. L. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.09.001 · Cited by 45
“…et al., 2009; Getahun et al., 2012), one study from New York showed that PWIDs and those who were homeless were independently associated with TB treatment nonadherence and non-adherent patients not only took longer to treat, but were more likely to develop MDR-TB (Pablos-Mendez et al., 1997).”
Result
Mobile phone short message service for adherence support and care of patients with tuberculosis infection: Evidence and opportunity
Lester, R. T., Park, J., Bolten, L. M., Enjetti, A., Johnston, J. C., Schwartzman, K., Tilahun, B. C., & von Delft, A. (2019) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2019.100108 · Cited by 47
“[4] Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR.”
Alcohol use and clinical manifestations of tuberculosis
Fiske, C. T., HAMILTON, C. D., & Stout, J. E. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.015 · Cited by 44
Adherence to HAART Among HIV-Infected Persons in Rural Louisiana
Mohammed, H. P., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., Rice, J. C., & KISSINGER, P. J. (2004) · AIDS Patient Care and STDs · doi:10.1089/108729104323076025 · Cited by 44
Predictors for Pulmonary Tuberculosis Treatment Outcome in Denmark 2009–2014
Holden, I. K., Lillebæk, T., Seersholm, N. J., Andersen, P. H., Wejse, C. M., & Johansen, I. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49439-9 · Cited by 42
Defaulting from tuberculosis treatment in the Netherlands: rates, risk factors and trend in the period 1993–1997
Borgdorff, M. W., Veen, J., Kalisvaart, N. A., Broekmans, J. F., & Nagelkerke, N. J. D. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16b05.x · Cited by 42
Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia
Jakubowiak, W., Bogorodskaya, E. M., Borisov, S. E., Danilova, I. N., & Kourbatova, E. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.07.015 · Cited by 40
“Non-adherent patients require longer periods of treatment and are less likely to complete treatment compared to patients who are compliant.(10,12) This study was therefore designed to determine the frequency and length of treatment interruptions among new patients with pulmonary TB in Russia, and to evaluate the durat…”
Background
Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation
Miller, A. C., Gelmanova, I. Y., Keshavjee, S. A., Atwood, S. S., Yanova, G. V., Mishustin, S. P., Furin, J. J., & Shin, S. S. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0795 · Cited by 40
Latent Tuberculosis among Persons at Risk for Infection with HIV, Tijuana, Mexico
Garfein, R. S., Laniado-Laborı́n, R., Rodwell, T. C., Lozada, R. M., Deiss, R., Burgos, J. L., Cuevas-Mota, J., Cerecer, P., Moser, K., Volker, M. L., et al. (2010) · Emerging infectious diseases · doi:10.3201/eid1605.091446 · Cited by 40
“quently, and drug users and homeless populations have additional barriers to compliance with TB treatment regimens (36,37).”
Background
Can tuberculosis be controlled?
Frieden, T. R. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.5.894 · Cited by 40
Factors Associated With Tuberculosis Treatment Interruption in New York City
Driver, C. R., Matus, S. P., Bayuga, S., Winters, A. I., & Munsiff, S. S. (2005) · Journal of Public Health Management and Practice · doi:10.1097/00124784-200507000-00017 · Cited by 39
Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
Anunnatsiri, S., Chetchotisakd, P., & WANKE, C. A. (2005) · PubMed · Cited by 39
Recruiting Older African American Men to a Cancer Screening Trial (The AAMEN Project)
Ford, M. E., Havstad, S. L., & Tilley, B. C. (2003) · The Gerontologist · doi:10.1093/geront/43.1.27 · Cited by 39
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial
Lee, J., Lee, J. Y., Kim, D. K., Yoon, H. I., Jeong, I., Heo, E. Y., Park, Y. S., Jo, Y. S., Lee, J. H., Park, S. S., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30480-8 · Cited by 38
Prevalence and predictive factors of tuberculosis treatment interruption in the Asia region: a systematic review and meta-analysis
Oh, A. L., Makmor‐Bakry, M., Islahudin, F. H., & Wong, I. C. K. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2022-010592 · Cited by 37
Antimicrobial activity of endophytic fungi isolated and identified from salt marsh plant in Vellar Estuary
Indira, K., Jayaprabha, N., & Muthukumaraswamy, S. (2015) · Journal of Microbiology and Antimicrobials · doi:10.5897/jma2014.0334 · Cited by 36
Drug addiction and alcoholism as predictors for tuberculosis treatment default in Brazil: a prospective cohort study
Silva, M. R., PEREIRA, J. C., da Costa, R. R., DIAS, J. A., Guimarães, M. D. C., & Leite, I. C. G. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817002631 · Cited by 36
“Non-adherence to, and default from, anti-TB treatments are serious challenges that are jeopardizing TB control worldwide, because these patients required longer treatment regimens, were more likely to acquire drug resistance and were less likely to complete treatment [22].”
Background
The Role of Adherence and Retreatment in De Novo Emergence of MDR-TB
Cadosch, D., Wiesch, P. A. Z., Kouyos, R. D., & Bonhoeffer, S. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004749 · Cited by 35
The diagnosis and management of multiple-drug-resistant tuberculosis at the beginning of the new millenium
Drobniewski, F. A., & Balabanova, Y. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90151-7 · Cited by 35
Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010
Báez-Saldaña, R., Delgado-Sánchez, G., García‐García, L., Cruz‐Hervert, L. P., Montesinos-Castillo, M., Ferreyra-Reyes, L. D., Bobadilla-del-Valle, M., Canizales‐Quintero, S., Ferreira-Guerrero, E., Téllez-Vázquez, N. A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168955 · Cited by 34
Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova
Jenkins, H. E., Ciobanu, A., Plesca, V., Crudu, V., Galusca, I., Soltan, V., & Cohen, T. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0464 · Cited by 33
Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults.
Nyamathi, A., Stein, J. A., Schümann, A., & Tyler, D. (2007) · Health Psychology · doi:10.1037/0278-6133.26.1.68 · Cited by 33
Are There Race/Ethnicity Differences in Outpatient Congestive Heart Failure Management, Hospital Use, and Mortality Among an Insured Population?
Lafata, J. E., Pladevall, M., Divine, G., Ayoub, M. A., & Philbin, E. F. (2004) · Medical Care · doi:10.1097/01.mlr.0000129903.12843.fc · Cited by 33
“This was achieved by using geographic information system technology to assign the average household income in the census block-group of residence to each study participant.(35,36) Automated medical group encounter data were also used to ascertain medical care service use delivered by a medical group provider.”
Method
The impact of physician training and experience on the survival of patients with active tuberculosis
Khan, K. Z. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060124 · Cited by 33
Prevalence and predictors of default from tuberculosis treatment in Hong Kong.
Chan-Yeung, M., Noertjojo, K., Leung, C. C., Chan, S. L., & Tam, C. M. (2003) · PubMed · Cited by 33
Balancing Act: Clinical Practices That Respond to the Needs of Homeless People
McMurray-Avila, M., Gelberg, L., & Breakey, W. R. (1999) · Cited by 32
Strategies to Decrease Tuberculosis in US Homeless Populations
Brewer, T. F., Heymann, J. S., Krumplitsch, S. M., Wilson, M. E., Colditz, G. A., & Fineberg, H. V. (2001) · JAMA · doi:10.1001/jama.286.7.834 · Cited by 32
“Chronically homeless population 88 (60-100) .”
Background
Encouraging patient adherence: primary care physicians’ use of verbal compliance-gaining strategies in medical interviews
Smith, V. A., DeVellis, B. M., Kalet, A. L., Roberts, J. C., & DeVellis, R. F. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2004.03.017 · Cited by 31
“Unfortunately, nonadherence is widespread [1,2] and its deleterious effects are well documented [3–6].”
Background
Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis
Meyssonnier, V., Bui, T. V., Véziris, N., Jarlier, V., & Robert, J. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-18 · Cited by 31
“The interest fluoroquinolones and aminoglycosides has been reported for MDR TB [27,28,35].”
Background
Factores sociales de riesgo para la falta de cumplimiento terapéutico en pacientes con tuberculosis en Pontevedra
Anibarro, L., Lires, J. A., Iglesias, F., Vilariño, C., Baloria, A., de Lis, J. M., & Ojea, R. (2004) · Gaceta Sanitaria · doi:10.1016/s0213-9111(04)71997-4 · Cited by 30
Impact of socio-psychological factors on treatment adherence of TB patients in Russia
Jakubowiak, W., Bogorodskaya, E. M., Borisov, S. E., Danilova, I. D., Ломакіна, О., & Kourbatova, E. V. (2008) · Tuberculosis · doi:10.1016/j.tube.2008.03.004 · Cited by 30

Authors: Pablos-Méndez, M., Knirsch, M., Barr, M., Lerner, M., & Frieden, M.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 1997-02
Volume: 102
Issue: 2
Pages: 164-170
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/s0002-9343(96)00402-0
OpenAlex: W2006094917
Cited by: 256
References: 54
Citations by year: 2026: 4 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 11 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 12 · 2013: 15 · 2012: 13
FWCI: 7.02
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1256 d)
Locations: The American Journal of Medicine (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: treatment default, antitubercular agents, predictors of non-adherence, people who inject drugs, homelessness, HIV infection, drug resistance, tuberculosis control, household income, tuberculosis mortality, treatment completion, public health interventions, social determinants of health, racial disparities in health care access, alcoholism, intravenous drug use
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Black or African American, Child, Child, Preschool, Female, Ill-Housed Persons, Humans, Income, Infant, Male, Middle Aged, New York City, Patient Compliance, Retrospective Studies, Risk Factors, Tuberculosis, Urban Health, Cohort Studies, Substance Abuse, Intravenous, Confidence Intervals, AIDS-Related Opportunistic Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks